Yingzhen Du

3.6k total citations · 2 hit papers
25 papers, 2.3k citations indexed

About

Yingzhen Du is a scholar working on Epidemiology, Infectious Diseases and Neurology. According to data from OpenAlex, Yingzhen Du has authored 25 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 6 papers in Infectious Diseases and 5 papers in Neurology. Recurrent topics in Yingzhen Du's work include Autophagy in Disease and Therapy (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and COVID-19 Clinical Research Studies (4 papers). Yingzhen Du is often cited by papers focused on Autophagy in Disease and Therapy (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and COVID-19 Clinical Research Studies (4 papers). Yingzhen Du collaborates with scholars based in China, United States and Hong Kong. Yingzhen Du's co-authors include Guogang Xu, Tianzhi Li, Runsheng Wang, Lei Tu, Qinyong Hu, Chao Hu, Mi Mu, Pengcheng Yang, Yu Sun and Jing Wang and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Cellular and Molecular Life Sciences.

In The Last Decade

Yingzhen Du

23 papers receiving 2.2k citations

Hit Papers

Clinical Characteristics of COVID-19 Patients With Digest... 2020 2026 2022 2024 2020 2020 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingzhen Du China 12 1.5k 816 354 297 277 25 2.3k
Qinyong Hu China 14 1.6k 1.0× 844 1.0× 502 1.4× 237 0.8× 293 1.1× 35 2.5k
Hongliu Cai China 16 1.6k 1.0× 774 0.9× 416 1.2× 318 1.1× 233 0.8× 51 2.7k
Mi Mu China 8 1.4k 0.9× 762 0.9× 339 1.0× 205 0.7× 165 0.6× 10 2.0k
Pengcheng Yang China 6 1.5k 1.0× 772 0.9× 343 1.0× 197 0.7× 154 0.6× 9 2.0k
Lei Tu China 20 1.6k 1.1× 863 1.1× 547 1.5× 288 1.0× 442 1.6× 62 3.1k
Stefanie W. Benoit United States 20 1.9k 1.3× 937 1.1× 473 1.3× 421 1.4× 232 0.8× 51 2.9k
Wen Wang China 21 997 0.7× 582 0.7× 368 1.0× 295 1.0× 465 1.7× 72 2.3k
Yongxi Zhang China 20 2.2k 1.4× 1.1k 1.4× 560 1.6× 460 1.5× 267 1.0× 56 3.0k
Xiaoyan Wu China 12 2.3k 1.5× 1.4k 1.7× 618 1.7× 449 1.5× 256 0.9× 31 3.3k

Countries citing papers authored by Yingzhen Du

Since Specialization
Citations

This map shows the geographic impact of Yingzhen Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingzhen Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingzhen Du more than expected).

Fields of papers citing papers by Yingzhen Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingzhen Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingzhen Du. The network helps show where Yingzhen Du may publish in the future.

Co-authorship network of co-authors of Yingzhen Du

This figure shows the co-authorship network connecting the top 25 collaborators of Yingzhen Du. A scholar is included among the top collaborators of Yingzhen Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingzhen Du. Yingzhen Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
5.
Zhu, Pingjun, X. L. Wang, Jianbo Zhu, et al.. (2024). BCAP31 Alleviates Lipopolysaccharide-Mediated Acute Lung Injury via Induction of PINK1/Parkin in Alveolar Epithelial Type II Cell. Research. 7. 498–498. 4 indexed citations
6.
Du, Yingzhen, Jialei Li, Yuxin Chen, et al.. (2024). Pyruvate kinase M2 sustains cardiac mitochondrial quality surveillance in septic cardiomyopathy by regulating prohibitin 2 abundance via S91 phosphorylation. Cellular and Molecular Life Sciences. 81(1). 254–254. 5 indexed citations
7.
Du, Yingzhen, Pingjun Zhu, Tian Xia, et al.. (2024). DNA-PKcs Phosphorylates Cofilin2 to Induce Endothelial Dysfunction and Microcirculatory Disorder in Endotoxemic Cardiomyopathy. Research. 7. 331–331. 9 indexed citations
8.
9.
Huang, Shuai, et al.. (2023). Lats2 deficiency protects the heart against myocardial infarction by reducing inflammation and inhibiting mitochondrial fission and STING/p65 signaling. International Journal of Biological Sciences. 19(11). 3428–3440. 11 indexed citations
10.
Zhan, Xi, Yingzhen Du, Chao Hu, et al.. (2022). Features of transbronchial lung cryobiopsy‐diagnosed fibrotic hypersensitivity pneumonitis. The Clinical Respiratory Journal. 17(1). 50–58. 3 indexed citations
11.
Luο, Xingguang, Xiaoyun Guo, Yong Zhang, et al.. (2021). Psychological responses among nurses caring for patients with COVID-19: a comparative study in China. Translational Psychiatry. 11(1). 273–273. 8 indexed citations
12.
Zhu, Pingjun, Kun Wan, Ming Yin, et al.. (2021). RIPK3 Induces Cardiomyocyte Necroptosis via Inhibition of AMPK‐Parkin‐Mitophagy in Cardiac Remodelling after Myocardial Infarction. Oxidative Medicine and Cellular Longevity. 2021(1). 6635955–6635955. 40 indexed citations
13.
Du, Yingzhen, Lei Tu, Pingjun Zhu, et al.. (2020). Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study. American Journal of Respiratory and Critical Care Medicine. 201(11). 1372–1379. 642 indexed citations breakdown →
14.
Du, Yingzhen, Pingjun Zhu, Xi Wang, et al.. (2020). Pirfenidone alleviates lipopolysaccharide-induced lung injury by accentuating BAP31 regulation of ER stress and mitochondrial injury. Journal of Autoimmunity. 112. 102464–102464. 33 indexed citations
15.
Xu, Guogang, Yongshi Yang, Yingzhen Du, et al.. (2020). Clinical Pathway for Early Diagnosis of COVID-19: Updates from Experience to Evidence-Based Practice. Clinical Reviews in Allergy & Immunology. 59(1). 89–100. 66 indexed citations
16.
Zhang, Zhijian, Jie Lu, Yingzhen Du, et al.. (2019). Comparison of in vitro synergistic effect between clarithromycin or azithromycin in combination with amikacin against Mycobacterium intracellulare. Journal of Global Antimicrobial Resistance. 18. 183–186. 3 indexed citations
17.
Du, Yingzhen, et al.. (2018). Genetic diversity of antigen 38 kDa in Mycobacterium tuberculosis strains from China. Tuberculosis. 110. 20–25. 2 indexed citations
18.
Wang, Xi, Yingzhen Du, Li Fan, et al.. (2013). Relationships between HDL-C, hs-CRP, with Central Arterial Stiffness in Apparently Healthy People Undergoing a General Health Examination. PLoS ONE. 8(12). e81778–e81778. 23 indexed citations
19.
Liu, Yu, Suozhu Shi, Zhaoyan Gu, et al.. (2012). Impaired autophagic function in rat islets with aging. AGE. 35(5). 1531–1544. 42 indexed citations
20.
Gu, Zhaoyan, Yingzhen Du, Yu Liu, et al.. (2011). Effect of aging on islet beta-cell function and its mechanisms in Wistar rats. AGE. 34(6). 1393–1403. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026